Evaluation of Pathological Complete Response Rate in Patients with HER2-Positive Breast Cancer Undergoing Neoadjuvant Trastuzumab and Chemotherapy With or Without Anthracycline
{{output}}
Objective: This study aimed to evaluate the pathological complete response rate (pCR) in HER2 breast cancer by comparing anthracycline-containing and anthracycline-free regimens. ... ...
